These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30896644)

  • 1. Comparison of oxcarbazepine efficacy and MHD concentrations relative to age and BMI: Associations among ABCB1, ABCC2, UGT2B7, and SCN2A polymorphisms.
    Yang X; Yan Y; Fang S; Zeng S; Ma H; Qian L; Chen X; Wei J; Gong Z; Xu Z
    Medicine (Baltimore); 2019 Mar; 98(12):e14908. PubMed ID: 30896644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ABCB1, ABCC2, UGT2B7 and HNF4α genetic polymorphisms on oxcarbazepine concentrations and therapeutic efficacy in patients with epilepsy.
    Shen C; Zhang B; Liu Z; Tang Y; Zhang Y; Wang S; Guo Y; Ding Y; Wang S; Ding M
    Seizure; 2017 Oct; 51():102-106. PubMed ID: 28837897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
    Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL
    Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Analysis of the Association Between CYP3A4/5, ABCB1 Genetic Polymorphisms and Oxcarbazepine Metabolism and Transport in Chinese Epileptic Patients with Oxcarbazepine Monotherapy and Bitherapy.
    Wang P; Yin T; Ma HY; Liu DQ; Sheng YA; Zhou BT
    J Pharm Pharm Sci; 2015; 18(3):256-65. PubMed ID: 26517132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy.
    Ma CL; Wu XY; Jiao Z; Hong Z; Wu ZY; Zhong MK
    Pharmacogenomics; 2015; 16(4):347-60. PubMed ID: 25823783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular Filtration Rate Is a Major Predictor of Clearance of Oxcarbazepine Active Metabolite in Adult Chinese Epileptic Patients: A Population Pharmacokinetic Analysis.
    Lin WW; Wang CL; Jiao Z; Yu XL; Zhang J; Zhang WB; Lin RF; Lin S; Lin XH
    Ther Drug Monit; 2019 Oct; 41(5):665-673. PubMed ID: 31033858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
    Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
    CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
    Li X; Wei S; Wu H; Zhang Q; Zhao Z; Mei S; Feng W; Wu Y
    Eur J Pediatr; 2023 Oct; 182(10):4509-4521. PubMed ID: 37493972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetic insights into ABCB1, ABCC2, CYP1A2, and CYP2B6 variants with epilepsy susceptibility among Egyptian Children: A retrospective case-control study.
    Attia ZR; Labib ME; Kelany AK; Alnefaie RM; Twab HA; Wahsh E; Abd El Azeem RA; Shaaban EIA; Elsaid AM; Alalawy AI; Elshazli RM; El Tantawi N
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113073. PubMed ID: 39265352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
    Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
    Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients.
    Yang Q; Hu Y; Zhang X; Zhang X; Dai H; Li X
    Eur J Hosp Pharm; 2023 Mar; 30(e1):e90-e96. PubMed ID: 35787526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
    Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH
    Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saliva and Plasma Monohydroxycarbamazepine Concentrations in Pediatric Patients With Epilepsy.
    Li RR; Sheng XY; Ma LY; Yao HX; Cai LX; Chen CY; Zhu SN; Zhou Y; Wu Y; Cui YM
    Ther Drug Monit; 2016 Jun; 38(3):365-70. PubMed ID: 26818624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the polymorphisms in the ATP-binding cassette genes ABCB1 and ABCC2 and the risk of drug-resistant epilepsy in a Chinese Han population.
    Xue T; Lu ZN
    Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27886333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsy.
    Peng J; Zhang HN; Liu ZS; Xu H; Wang Y
    Int J Clin Pharmacol Ther; 2014 Aug; 52(8):684-92. PubMed ID: 24887335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and dose simulation of oxcarbazepine in Chinese paediatric patients with epilepsy.
    Chen CY; Zhou Y; Cui YM; Yang T; Zhao X; Wu Y
    J Clin Pharm Ther; 2019 Apr; 44(2):300-311. PubMed ID: 30636182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level monitoring of oxcarbazepine in epileptic patients.
    González-Esquivel DF; Ortega-Gavilán M; Alcántara-López G; Jung-Cook H
    Arch Med Res; 2000; 31(2):202-5. PubMed ID: 10880728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of influencing factors on monohydroxylated derivative of oxcarbazepine plasma concentration in children with epilepsy.
    Yao N; Huang S; Huang A; Song H
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1667-1675. PubMed ID: 36006433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
    Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
    Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.